Minocromil

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H16N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F37A9VKY5Q, chemically known as 6-(methylamino)-4-oxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid but generally known as minocromil, which bears US NIH Compound Identifier 71448. European Medicines Agency schedules Minocromil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08979MIG. The term MINOCROMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). MINOCROMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule minocromil under HS 29349990 and SITC 51579. As of Q4 2014, MINOCROMIL remains the US FDA Preferred Term for this commodity. Minocromil bears US NLM identifiers UMLS ID C0066572 and NCI Concept Code C66162. SMILES: O1C2C(CCC)C3NC(CC(NC)C3CC2C(=O)CC1C(=O)O)C(=O)O.